Trial intelligence / Profile preview

Anakinra in hidradenitis suppurativa

NCT01558375Phase 2Completed

Sponsor
National and Kapodistrian University of Athens
Start
Mar 2012
Primary completion
Feb 2014
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Anakinra Arm with Placebo Arm (2 arms). Primary endpoints: Visual Analogue Scale at 24 weeks, Disease Activity at 24 weeks and 2 more. Started Mar 2012; status: completed.

02

Drugs

anakinra
03

Conditions

hidradenitis suppurativa (HS)

Beyond the preview

Go deeper on NCT01558375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01558375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call